Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Volume 309, Issue 6, Pages H1029-H1038
Publisher
American Physiological Society
Online
2015-08-01
DOI
10.1152/ajpheart.00527.2015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fibroblast Growth Factor 21 Prevents Atherosclerosis by Suppression of Hepatic Sterol Regulatory Element-Binding Protein-2 and Induction of Adiponectin in Mice
- (2015) Z. Lin et al. CIRCULATION
- Serum fibroblast growth factor 21 levels are increased in atrial fibrillation patients
- (2015) Xinyuan Han et al. CYTOKINE
- Fructose ingestion acutely stimulates circulating FGF21 levels in humans
- (2015) Jody R. Dushay et al. Molecular Metabolism
- Fibroblast growth factor 21 protects the heart from oxidative stress
- (2014) Anna Planavila et al. CARDIOVASCULAR RESEARCH
- The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study
- (2014) Kwok-Leung Ong et al. DIABETOLOGIA
- Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
- (2014) Jacob A. Udell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Novel Insights into the Cardio-Protective Effects of FGF21 in Lean and Obese Rat Hearts
- (2014) Vanlata Patel et al. PLoS One
- FGF21 Promotes Endothelial Cell Angiogenesis through a Dynamin-2 and Rab5 Dependent Pathway
- (2014) Usman Yaqoob et al. PLoS One
- Serum Fibroblast Growth Factor-21 Levels Are Associated With Carotid Atherosclerosis Independent of Established Cardiovascular Risk Factors
- (2013) Wing Sun Chow et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Proteomic study on the protective mechanism of fibroblast growth factor 21 to ischemia–reperfusion injury
- (2013) Wei-Tao Cong et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
- (2013) Yun Shen et al. Cardiovascular Diabetology
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- Serum fibroblast growth factor 21 is predictive of combined cardiovascular morbidity and mortality in patients with type 2 diabetes at a relatively short-term follow-up
- (2013) M. Lenart-Lipińska et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy
- (2013) T.-I. Lee et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- DVC1-0101 to Treat Peripheral Arterial Disease: A Phase I/IIa Open-label Dose-escalation Clinical Trial
- (2013) Yoshikazu Yonemitsu et al. MOLECULAR THERAPY
- Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease
- (2013) R. L. Davis et al. NEUROLOGY
- Circulating Fibroblast Growth Factor 23 Is Associated with Angiographic Severity and Extent of Coronary Artery Disease
- (2013) Yunjun Xiao et al. PLoS One
- Serum Levels of Fibroblast Growth Factor 19 Are Inversely Associated with Coronary Artery Disease in Chinese Individuals
- (2013) Yaping Hao et al. PLoS One
- Fibroblast growth factor 21 protects against cardiac hypertrophy in mice
- (2013) A. Planavila et al. Nature Communications
- Endocrine Protection of Ischemic Myocardium by FGF21 from the Liver and Adipose Tissue
- (2013) Shu Q. Liu et al. Scientific Reports
- Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia
- (2012) Shu Q. Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- A preliminary study of the potential role of FGF-23 in coronary calcification in patients with suspected coronary artery disease
- (2012) Hirofumi Masai et al. ATHEROSCLEROSIS
- Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status
- (2012) Yenna Lee et al. CLINICAL ENDOCRINOLOGY
- Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques
- (2012) So-Yeon An et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- FGF21 regulates PGC-1 and browning of white adipose tissues in adaptive thermogenesis
- (2012) f. M. Fisher et al. GENES & DEVELOPMENT
- Fibroblast Growth Factor-21 (FGF21) Regulates Low-density Lipoprotein Receptor (LDLR) Levels in Cells via the E3-ubiquitin Ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting Saposin-like Protein (Msap)
- (2012) Hai Thi Do et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis
- (2012) Thomas Reinehr et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes
- (2012) Kwok Leung Ong et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast growth factor-21 serum concentrations are associated with metabolic and hepatic markers in humans
- (2012) Susan Kralisch et al. JOURNAL OF ENDOCRINOLOGY
- Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults
- (2012) R D Semba et al. JOURNAL OF HUMAN HYPERTENSION
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
- (2012) Joachim H. Ix et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis
- (2011) Eleni M Domouzoglou et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
- (2011) Eric T. Sawey et al. CANCER CELL
- Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women
- (2011) Sae Jeong Yang et al. CLINICAL ENDOCRINOLOGY
- Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently
- (2011) Xuesong Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Integrated Regulation of Hepatic Metabolism by Fibroblast Growth Factor 21 (FGF21)in Vivo
- (2011) ffolliott M. Fisher et al. ENDOCRINOLOGY
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
- (2011) N. Itoh et al. JOURNAL OF BIOCHEMISTRY
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia
- (2011) Jill Belch et al. LANCET
- Pericardial Fat Is Associated With Prevalent Atrial Fibrillation
- (2010) George Thanassoulis et al. Circulation-Arrhythmia and Electrophysiology
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
- (2010) Yusuf Yilmaz et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
- (2010) Huating Li et al. JOURNAL OF HEPATOLOGY
- Research Resource: Comprehensive Expression Atlas of the Fibroblast Growth Factor System in Adult Mouse
- (2010) Klementina Fon Tacer et al. MOLECULAR ENDOCRINOLOGY
- Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile
- (2010) Zhuofeng Lin et al. PLoS One
- Relevant use of Klotho in FGF19 subfamily signaling system in vivo
- (2010) K.-i. Tomiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
- (2009) Heng Jung Hsu et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Fibroblast Growth Factor 21-Deficient Mice Demonstrate Impaired Adaptation to Ketosis
- (2009) Michael K. Badman et al. ENDOCRINOLOGY
- Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study
- (2009) A. A. Mahabadi et al. EUROPEAN HEART JOURNAL
- Local Gene Transfer and Expression Following Intramuscular Administration of FGF-1 Plasmid DNA in Patients With Critical Limb Ischemia
- (2009) Iris Baumgartner et al. MOLECULAR THERAPY
- Relationship between circulating FGF23 and total body atherosclerosis in the community
- (2009) Majd A. I. Mirza et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Circulating Metabolic Regulator FGF21 Is Induced by Prolonged Fasting and PPARα Activation in Man
- (2008) Cecilia Gälman et al. Cell Metabolism
- Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity
- (2008) M. Mraz et al. CLINICAL ENDOCRINOLOGY
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- Plasma FGF-21 levels in type 2 diabetic patients with ketosis
- (2008) Ling Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
- Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia
- (2008) Sigrid Nikol et al. MOLECULAR THERAPY
- FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons
- (2008) Vikram G. Shakkottai et al. NEUROBIOLOGY OF DISEASE
- Fibroblast Growth Factor 4 and Its Novel Splice Isoform Have Opposing Effects on the Maintenance of Human Embryonic Stem Cell Self-Renewal
- (2008) Yoav Mayshar et al. STEM CELLS
- FGF-21/FGF-21 receptor interaction and activation is determined by βKlotho
- (2007) Alexei Kharitonenkov et al. JOURNAL OF CELLULAR PHYSIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search